A.A. Azamatov
1 ta ish
C.Yu.Yunusov Nomidagi O’simlik Moddalari Kimyosi Instituti
SELECTING PRECLINICAL MODELS OF PARKINSON’S DISEASE IN DRUG DEVELOPMENT: CRITERIA AND LIMITATIONS
Akhmadjonov K.K., A.A. Azamatov, U.A. Kurbonov +1
proceedingOchiq kirish20260 iqtibosABI